Stifel lowered the firm’s price target on Cipher Pharmaceuticals (CPHRF) to C$17 from C$19 and keeps a Buy rating on the shares. The views and opinions expressed herein are the views and opinions of ...
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) ("Cipher" or the "Company") today announced its third quarter 2025 financial results, as well as an update on its ...
H.C. Wainwright’s model assumes Cipher will convert 10% of its 2.4 GW development pipeline for future HPC/AI opportunities, while noting potential risks including Bitcoin price volatility, network ...
Paris (France), Copenhagen (Denmark), April 13, 2015 [7:00 pm CET] - Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology ...
H.C. Wainwright on Tuesday turned bullish on Cipher Mining (NASDAQ:CIFR), citing strong execution, "best-in-class" mining economics and higher bitcoin (BTC-USD) prices. "We are upgrading shares of ...
H.C. Wainwright also applied a 10x revenue multiple to contracted annual revenue streams from Fluidstack and AWS colocation agreements for Cipher’s high-performance computing (HPC) business. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results